Monivent AB (XSAT:MONI) Current Deferred Revenue: kr0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:MONI Monivent AB XSAT:MONI
23 GF Score
Price kr0.19
GF Value kr0.04
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Monivent AB Current Deferred Revenue?

Monivent AB XSAT:MONI 23 Current Deferred Revenue is kr0.00 Mil as of Mar. 2026. GuruFocus rates XSAT:MONI with a GF Score™ of 23/100 and a GF Value™ of kr0.04 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Monivent AB's current deferred revenue for the quarter that ended in Mar. 2026 was kr0.00 Mil.

Monivent AB Current Deferred Revenue Related Terms

Monivent AB Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Monivent AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monivent AB Current Deferred Revenue Chart

Monivent AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Monivent AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSAT:MONI
23GF Score
Monivent AB XSAT:MONI
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of kr0.00 Mil mean?
Monivent AB (XSAT:MONI) has a Current Deferred Revenue of kr0.00 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Monivent AB and its competitors.
Is Monivent AB's Current Deferred Revenue too high?
Monivent AB's current Current Deferred Revenue is kr0.00 Mil. Overall, Monivent AB has a GF Score™ of 23/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monivent AB's Current Deferred Revenue compare to ABT and SYK?
Monivent AB's Current Deferred Revenue of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Monivent AB and its competitors. Monivent AB's current Current Deferred Revenue is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monivent AB stock overvalued right now?
Based on GuruFocus' analysis, Monivent AB (XSAT:MONI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.04, compared to a current price of kr0.19 — trading 372.5% above its estimated fair value. The current Current Deferred Revenue is kr0.00 Mil. Monivent AB's overall GF Score™ is 23/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Monivent AB (XSAT:MONI), the current Current Deferred Revenue is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monivent AB (XSAT:MONI) Overvalued in 2026?

Based on GuruFocus' analysis, Monivent AB stock appears to be overvalued. The current stock price of kr0.19 is trading 372.5% above its estimated GF Value™ of kr0.04. GuruFocus considers Monivent AB to be Significantly Overvalued.

Key valuation signals for XSAT:MONI:

  • Current Deferred Revenue: kr0.00 Mil
  • GF Value™: kr0.04 vs. price of kr0.19 (372.5% above fair value)
  • GF Score™: 23/100 with 5 warning signs

No single metric tells the full story. See the XSAT:MONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monivent AB Business Description

Address Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.
23GF Score

Get the complete analysis for XSAT:MONI

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.19
Price
kr0.04
GF Value